Related Experiment Videos
[Coronary stenosis and mechanisms of collateral vessel growth]
Insights
Collateral circulation in coronary artery disease develops through angiogenesis and arteriogenesis, influenced by growth factors like VEGF. Understanding these mechanisms is key for developing therapeutic angiogenesis strategies.
Area of Science:
- Cardiovascular Biology
- Vascular Biology
- Molecular Cardiology
Context:
- Coronary artery disease (CAD) progression is significantly influenced by the development of collateral circulation.
- Collateral vessels form via two primary mechanisms: angiogenesis (capillary sprouting) and arteriogenesis (in situ development from arterioles).
- This process is regulated by multiple angiogenic growth factors, including vascular endothelial growth factor (VEGF), fibroblast growth factors (FGFs), insulin-like growth factor-1 (IGF-1), and platelet-derived growth factor (PDGF).
Purpose:
- To explore the mechanisms of collateral vessel development in the context of coronary artery disease.
- To investigate the role of angiogenic growth factors and their receptors in collateral formation.
- To address existing controversies regarding the regulation of angiogenesis in response to pathological stimuli.
Summary:
- Collateral circulation, crucial for managing coronary artery disease, arises from angiogenesis and arteriogenesis.
- Angiogenic growth factors like VEGF, FGFs, IGF-1, and PDGF mediate collateral development.
- Debate persists on whether increased growth factor supply or receptor upregulation drives angiogenesis in pathological conditions.
Impact:
- Enhanced understanding of collateral vessel biology can guide the development of novel therapeutic angiogenesis strategies.
- Identifying key regulatory pathways may lead to improved treatments for ischemic heart disease.
- This research provides a foundation for future clinical interventions aimed at promoting vascular repair.
Abstract:
The presence or absence of collateral circulation significantly impacts the natural history of coronary artery disease. Collateral growth involves two different mechanism; capillary collaterals develop by sprouting (angiogenesis) and muscular collaterals develop in situ from preexisting arterioles (arteriogenesis). The process is mediated by various angiogenic growth factors such as VEGF, FGFs, IGF-1 and PDGF. Although these growth factors have been studied extensively, controversies still exist as to whether angiogenesis depends on increased supply of these growth factors or their receptors are upregulated by the underlying pathological situation. An increased understanding of the basic biology of collateral vessel development would be instrumental in the establishment of therapeutic angiogenesis.